The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Interventional Oncology Market Between 2026 And 2030?
The interventional oncology market has experienced robust growth in recent years. Projections indicate this market will expand from $2.72 billion in 2025 to $2.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be attributed to several factors including rising global cancer incidence rates, the expansion of interventional radiology services, a growing preference for minimally invasive procedures, improved availability of imaging-guided devices, and increased hospital oncology investments.
The interventional oncology market is projected to experience substantial expansion in the coming years. This market is set to reach $4.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. The anticipated growth during this period is largely driven by factors such as the increasing integration of AI-assisted imaging guidance, a surging demand for outpatient cancer therapies, the broader application of personalized oncology strategies, increasing financial commitments to cutting-edge ablation technologies, and an intensified emphasis on minimizing patient recovery periods. Key trends foreseen over the forecast horizon encompass the wider embrace of image-guided cancer treatments, a growing preference for minimally invasive ablation techniques, the deepening integration of sophisticated imaging modalities, the broadening scope of targeted tumor therapy methods, and a heightened dedication to precision oncology.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report
What Significant Factors Are Influencing The Interventional Oncology Market Expansion?
The growing incidence of cancer is projected to fuel the expansion of the interventional oncology market moving forward. Cancer prevalence refers to the total number of individuals, both newly and previously diagnosed, who are currently living with a history of cancer at a specific moment. This rise in cancer prevalence is linked to lifestyle-related factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, all of which elevate the risk of developing various cancers. Interventional oncology supports cancer treatment through minimally invasive, targeted therapies that concentrate directly on tumors. This method enhances patient outcomes by minimizing damage to healthy tissue and facilitating quicker recovery times compared to conventional treatments. For instance, in February 2024, the World Health Organization, a Switzerland-based international organization dedicated to global health, forecast over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is a key driver for the growth of the interventional oncology market.
How Are Different Segments Classified In The Interventional Oncology Market Segment Analysis?
The interventional oncology market covered in this report is segmented –
1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices
2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided
3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care
4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer
5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions
Subsegments:
1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems
3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices
What Trends Are Affecting The Direction Of The Interventional Oncology Market?
Leading firms within the interventional oncology market are concentrating efforts on creating sophisticated products, like microcatheter-based embolization systems, designed to administer precise, targeted cancer treatment while reducing harm to adjacent healthy tissue. These microcatheter-based embolization systems are medical instruments that employ minute, pliable catheters to accurately introduce embolic agents into blood vessels, aiming to obstruct or diminish blood flow, commonly utilized for addressing tumors, vascular abnormalities, or hemorrhages. As an illustration, during March 2025, Terumo Corporation, a Japanese medical device enterprise, introduced the Occlusafe balloon occlusion catheter, leveraging its cutting-edge Balloon-TACE (B-TACE) therapy for managing liver cancer, specifically hepatocellular carcinoma (HCC). This particular microcatheter utilizes the pressure gradient effect to reroute blood flow and reach the microcirculation, thereby allowing for elevated concentrations of therapeutic agents at the tumor location and simultaneously limiting off-target embolization. The goal of this focused methodology is to enhance clinical results in challenging liver cancer instances by boosting the accuracy of drug delivery and providing better visualization throughout interventions.
Who Are The Companies Driving Activity In The Interventional Oncology Market?
Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet SA, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited, Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Medtronic plc, Koninklijke Philips NV, Cook Medical Incorporated
Get The Full Interventional Oncology Market Report:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report
Which Region Leads The Interventional Oncology Market In Terms Of Market Share?
North America was the largest region in the interventional oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Interventional Oncology Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report
Browse Through More Reports Similar to the Global Interventional Oncology Market 2026, By The Business Research Company
Transportation Infrastructure Construction Market Report 2026
Residential Building Construction Market Report 2026
Construction Market Report 2026
https://www.thebusinessresearchcompany.com/report/construction-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model